Fiona Campbell

Summary

Affiliation: University of Liverpool
Country: UK

Publications

  1. ncbi Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin
    Fiona Campbell
    Department of Pathology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK
    Histopathology 55:277-83. 2009
  2. ncbi Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio
    Richard A Smith
    Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool, L69 3GA, UK
    J Gastrointest Surg 12:1422-8. 2008
  3. ncbi A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours
    Nicole Sakka
    Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Liverpool, UK
    Pancreatology 9:670-6. 2009
  4. ncbi Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
    Richard A Smith
    Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, Liverpool, UK
    Am J Surg 197:466-72. 2009
  5. ncbi The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells
    Adnan A Sheikh
    Division of Surgery and Oncology, Royal Liverpool University Hospital, University of Liverpool, Liverpool, UK
    Proteomics 7:1929-40. 2007
  6. ncbi High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients
    Dale Vimalachandran
    Division of Surgery and Oncology, Department of Pathology, University of Liverpool, Liverpool, Merseyside, UK
    Cancer Res 65:3218-25. 2005
  7. ncbi The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer
    Richard A Smith
    Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Liverpool, UK
    Surgery 143:658-66. 2008
  8. ncbi Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
    Adam Lister
    MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, UK
    Mol Cancer 10:37. 2011
  9. ncbi Prognostic potential of hepatocyte volume and cytokine expression in cirrhotic portal hypertension
    Saboor Khan
    Department of Surgery, University of Liverpool, Liverpool, UK
    J Gastroenterol Hepatol 20:1519-26. 2005
  10. ncbi Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
    Keith Leiper
    Department of Gastroenterology, University of Liverpool, Liverpool, UK
    Gut 60:1520-6. 2011

Collaborators

  • Robert Sutton
  • Tatjana Crnogorac-Jurcevic
  • Dale Vimalachandran
  • Neil R Kitteringham
  • Andrew Owen
  • Helmut Friess
  • B Kevin Park
  • Rosalind E Jenkins
  • William Greenhalf
  • Richard A Smith
  • John P Neoptolemos
  • Paula Ghaneh
  • Michael Raraty
  • Eithne Costello
  • Adam Lister
  • Keith Leiper
  • Taoufik Nedjadi
  • Nicole Sakka
  • Lorraine Bosonnet
  • Adnan A Sheikh
  • Andrew Dodson
  • Christopher C Thompson
  • Wendy Prime
  • Saboor Khan
  • Nicholas R Lemoine
  • Ali R Shekouh
  • Jonathan M Rhodes
  • Steve E Christmas
  • Anthony Ellis
  • Kate Martin
  • Samantha Williams
  • Sreedhar Subramanian
  • Ian M Copple
  • Bryony Lloyd
  • Chris E Goldring
  • Deborah Howarth
  • Alastair J Watson
  • Philip Whelan
  • Priya Healey
  • Connall Garvey
  • Mark Hughes
  • Johnathan Evans
  • Ali Shekouh
  • Anthony Kawesha
  • J Steven Grime
  • Mair Critchley
  • Jane Hamlett
  • C Simon Herrington
  • Stephen R Pennington
  • Markus W Buechler

Detail Information

Publications11

  1. ncbi Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin
    Fiona Campbell
    Department of Pathology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK
    Histopathology 55:277-83. 2009
    ....
  2. ncbi Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio
    Richard A Smith
    Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool, L69 3GA, UK
    J Gastrointest Surg 12:1422-8. 2008
    ..The objective of this study was to evaluate whether preoperative CA19-9 levels and the platelet-lymphocyte ratio (PLR) might reflect prognostic indices for resected ampullary adenocarcinoma...
  3. ncbi A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours
    Nicole Sakka
    Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Liverpool, UK
    Pancreatology 9:670-6. 2009
    ..To identify potential preoperative prognostic factors in resected pancreatic and periampullary neuroendocrine tumours...
  4. ncbi Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
    Richard A Smith
    Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, Liverpool, UK
    Am J Surg 197:466-72. 2009
    ..The objective of this study was to investigate whether the preoperative platelet-lymphocyte (P/L) ratio represents a significant prognostic index in resected pancreatic ductal adenocarcinoma...
  5. ncbi The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells
    Adnan A Sheikh
    Division of Surgery and Oncology, Royal Liverpool University Hospital, University of Liverpool, Liverpool, UK
    Proteomics 7:1929-40. 2007
    ..In conclusion, our study provides an extensive analysis of S100A8 and S100A9 in pancreatic disease and highlights a potentially important relationship between pancreatic cancer cells and their surrounding microenvironment...
  6. ncbi High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients
    Dale Vimalachandran
    Division of Surgery and Oncology, Department of Pathology, University of Liverpool, Liverpool, Merseyside, UK
    Cancer Res 65:3218-25. 2005
    ..Our results suggest that up-regulation of S100A6 is an early event in pancreatic cancer development and that elevated levels of nuclear S100A6 may affect clinical outcome...
  7. ncbi The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer
    Richard A Smith
    Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Liverpool, UK
    Surgery 143:658-66. 2008
    ....
  8. ncbi Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
    Adam Lister
    MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, UK
    Mol Cancer 10:37. 2011
    ..The Nrf2/Keap1 system is dysregulated in lung, head and neck, and breast cancers and this affects cellular proliferation and response to therapy. Here, we have investigated the integrity of the Nrf2/Keap1 system in pancreatic cancer...
  9. ncbi Prognostic potential of hepatocyte volume and cytokine expression in cirrhotic portal hypertension
    Saboor Khan
    Department of Surgery, University of Liverpool, Liverpool, UK
    J Gastroenterol Hepatol 20:1519-26. 2005
    ..Liver cytokine expression 3 weeks following an acute variceal bleed did not appear useful in determining prognosis...
  10. ncbi Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
    Keith Leiper
    Department of Gastroenterology, University of Liverpool, Liverpool, UK
    Gut 60:1520-6. 2011
    ..To assess the safety and efficacy of the B lymphocyte (anti-CD20) antibody, rituximab, in the treatment of steroid-resistant moderately active ulcerative colitis (UC)...
  11. ncbi Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma
    Ali R Shekouh
    Department of Surgery, Royal Liverpool University Hospital, University of Liverpool, UK
    Proteomics 3:1988-2001. 2003
    ..These observations indicate that the combination of LCM with 2-DE provides an effective strategy to discover proteins that are differentially expressed in PDAC...